10-K/A

AMENDMENT NO. 1 TO FORM 10-K

Company: FILANA THERAPEUTICS, INC.
Filed: May 9, 2012
Period of Report: December 31, 2005
Accession Number: 0001193125-12-222392

View Document ↗ View on SEC.gov ↗